Igenomix
Business Services · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7955 NW 12th St Ste 415, Miami, Florida,...Phone Number
(905) 565-9495Website
www.igenomix.caRevenue
<$5 MillionIndustry
About Igenomix
Igenomix Org Chart
Is Igenomix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Igenomix has recently received funding, and reach out quickly before it becomes old news!
Click to see if Igenomix had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Igenomix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Igenomix launches new products
Congratulate Masked Content for being promoted to Masked Content at Igenomix
Earning: See what the market has to say on Igenomix recently announced quarterly report
Website visits: Recent activity has been detected on your website
Igenomix, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Igenomix is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Igenomix as Masked Content
Find 3 more new buyers
Compare Similar Companies to Igenomix
Compare insights from companies similar to Igenomix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Igenomix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Igenomix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Igenomix.
Igenomix Tech Stack
A closer look at the technologies used by Igenomix
Most Recent Scoops
Igenomix News & Media
Vitrolife announces changes to the executive management team after the acquisition of Igenomix
GÖTEBORG, Sweden, Dec. 1, 2021 /PRNewswire/ -- As announced on 30 November, 2021, Vitrolife AB (publ) completed the acquisition of Igenomix, as a result, changes will be made to the executive management team effective 1 January, 2022. The executive management team will from 1 January,...Vitrolife completes the acquisition of Igenomix and carries out a non-cash consideration issue
On July 8, 2021, Vitrolife AB (publ) (“Vitrolife”) entered into a definitive agreement to acquire 100% of the shares in Igenomix S.L.[1] (“Igenomix”) from EQT and other shareholders (the “Transaction”). The conditions for the Transaction, including regulatory approvals such as merger control clearances, have been fulfilled and the acquisition of Igenomix is consequently completed. The Extraordinary General Meeting resolved on October 20, 2021 to approve the non-cash consideration issue in accordInterim report January - September 2021: Profitable growth and Igenomix acquisition
GÖTEBORG, Sweden, Oct. 29, 2021 /PRNewswire/ -- Interim report January – September 2021: Profitable growth and Igenomix acquisition. Third quarter: Sales amounted to SEK 406 (320) million, corresponding to an increase of 27 percent in SEK. Sales increased by 30 percent in local currency....EQT to sell Igenomix to Vitrolife
EQT Private Equity has agreed to sell Igenomix to Vitrolife.
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Igenomix
Igenomix is a medical testing laboratory specializing in reproductive genetic services, founded in 2011. The company offers pioneering tests to assist reproductive health professionals in diagnosing and treating patients, focusing on preconception, preimplantation, and prenatal genetic assessments. Igenomix collaborates with clinics and fertility d... Read More